Next Article in Journal
Flashbulb Memories in the Communication of the Diagnosis of Visual Impairment: The Effect of Context and Content
Next Article in Special Issue
Parent-Integrated Interventions to Improve Language Development in Children Born Very Preterm
Previous Article in Journal
Bimaxillary Dentoalveolar Protrusion Case Treated with Anchorage by Buccally Implemented Mini-Implants Using a 3D-Printed Surgical Guide
Previous Article in Special Issue
Parental Narratives of Bonding and Relational Experiences with Preterm Infants Born at 23 to 24 Weeks—A Qualitative Descriptive Study
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Redefining Neurodevelopmental Impairment: Perspectives of Very Preterm Birth Stakeholders

1
Department of Pediatrics, University of British Columbia and BC Children’s Hospital Research Institute, Vancouver, BC V5Z 4H4, Canada
2
Department of Pediatrics, University of British Columbia, Vancouver, BC V6T 1Z4, Canada
3
BC Children’s Hospital Research Institute, Vancouver, BC V5Z 4H4, Canada
4
CHU Sainte-Justine, Montreal, QC H3T 1C5, Canada
5
Science and Mathematics Education Research Group, Faculty of Education, McGill University, Montreal, QC H3A 0G4, Canada
6
Department of Pediatrics, Bureau de l’Éthique Clinique (BEC), Université de Montréal, QC H3C 3J7, Canada
7
Division of Neonatology, Unité d’Éthique Clinique, Unité de Soins Palliatifs, Bureau du Partenariat Patients-Familles-Soignants, Montréal, QC H3T 1C5, Canada
8
Department of Pediatrics, Université de Montréal, CHU Sainte-Justine, Montréal, QC H3T 1C5, Canada
*
Author to whom correspondence should be addressed.
Current address: Department of Arts and Sciences, Queen’s University, Kingston, ON K7L 3N6, Canada.
Children 2023, 10(5), 880; https://doi.org/10.3390/children10050880
Submission received: 14 April 2023 / Revised: 5 May 2023 / Accepted: 8 May 2023 / Published: 14 May 2023
(This article belongs to the Special Issue Family-Oriented Research to Improve Care of Preterm Infants)

Abstract

:
Children born very preterm are at risk of severe neurodevelopmental impairment, a composite endpoint that includes cerebral palsy, developmental delay, and hearing and visual impairment defined by medical professionals. We aimed to describe preterm birth stakeholders’ perspectives on this classification. Ten clinical scenarios describing 18-month-old children with different components of severe neurodevelopmental impairment and one scenario of a typically developing child (control) were distributed to parents and stakeholders using a snowball sampling technique. For each scenario, participants rated health on a scale from 0 to 10 and whether the scenario represented a severe condition. Results were analyzed descriptively and mean differences from the control scenario were compared using a linear mixed-effects model. Stakeholders (number = 827) completed 4553 scenarios. Median health scores for each scenario varied from 6 to 10. The rating for the cerebral palsy and language delay scenario was significantly lower (mean difference −4.3; 95% confidence interval: −4.4, −4.1) than the control. The proportion of respondents rating a scenario as “severe” ranged from 5% for cognitive delay to 55% for cerebral palsy and language delay. Most participants disagreed with the rating used in research to describe severe neurodevelopmental impairment in preterm children. The term should be redefined to align with stakeholder perceptions.

1. Introduction

Prematurity, defined as a live birth before 37 completed weeks’ gestation, is a global problem affecting more than 10% of births and 15 million babies every year [1]. Preterm birth rates vary. In 2021, of all live-born children in the USA, 10.5% were born preterm [2] and in Canada, 8% were born preterm with 6.4% born at 33–36 weeks’, 1% at 29–32 weeks’, and 0.6% born extremely preterm at <29 weeks’ gestation [3].
Internationally, prematurity is responsible not only for 35% of newborn deaths and 18% of deaths before age 5 years [1] but is also associated with an increased risk of neonatal complications, long-term morbidities [4], and higher healthcare costs [5,6] with the highest impact in the extreme preterm population. Evaluating outcomes of prematurity is essential for clinicians, parents, and the healthcare system to improve the future of children born preterm.
Unlike survival, the evaluation of long-term outcomes is challenging. In the last 50 years there have been numerous studies documenting long-term neurodevelopmental and health outcomes associated with prematurity. The use of standardized developmental tests to evaluate preterm outcomes objectively started with Drillien’s study of physical growth and mental development in children born weighing less than 3 pounds in Edinburgh between 1953 and 1955 [7]. The use of standardized neurodevelopmental tests became a common outcome measure in the scientific community thereafter. Cerebral palsy and visual and hearing impairments occur more frequently in the preterm population [4] and it became common practice to report a composite outcome of severe neurodevelopmental impairment which included cerebral palsy, deafness, blindness, and a score of below −2 or −3 standard deviations below the mean on a standardized neurodevelopmental test [4,8]. To minimize attrition, a neurodevelopmental assessment will often occur at a corrected age of 18–36 months. At this age the Bayley Scales of Infant and Toddler Development [9] is a frequently used developmental test. Neonatal follow-up programs incorporate these assessments into standard care [10,11]. The reported research using these outcomes is the foundation for life and death decisions such as resuscitation at the threshold of viability [12,13].
Communication with parents, as legal guardians and advocates for their child, is essential and should be parent-personalized [14]. Healthcare professionals need to provide parents with the information they need in language they understand. The available research data frequently use the term “severe neurodevelopmental impairment”, a composite outcome that includes several sensory and neurodevelopmental components as the primary outcome in observational studies [15,16,17] and clinical trials [8]. Composite outcomes require that the individual components are of equal significance [18,19,20]. Yet, there is a paucity of research on whether the individual components have a similar impact on the child and family. Preterm outcome research has been dominated by the use of researcher-determined outcomes and definitions and parents have not been asked what outcomes are important to them.
The goal of our research, part of the patient-oriented research network Child Health Initiatives Limiting Disability - Brain Research Improving Growth and Health Trajectories [21] was to identify outcome measures that are meaningful to parents of children born very preterm. In this study, our aim was to investigate stakeholders’ perspectives on the classification and definitions of neurodevelopment used to describe children born preterm. Stakeholder perceptions of the Canadian Neonatal Follow-Up Network (CNFUN) [22] definition of “severe” neurodevelopmental impairment were explored, as well as the equivalence of the components used to define severe neurodevelopmental impairment.

2. Materials and Methods

The opinions of preterm birth stakeholders including parents, individuals born preterm, healthcare professionals, researchers, trainees, and educators were captured using a cross-sectional survey.

2.1. Development of the Clinical Scenarios

The composite outcome, severe neurodevelopmental impairment, used by the CNFUN has similar components to those outcomes used by other neonatal outcome researchers. Information is collected at an in-person assessment at a targeted age of 18–21 months corrected age. Severe neurodevelopmental impairment includes one or more of the following: Bayley Scales of Infant and Toddler Development third edition (Bayley-III) [9] cognitive, motor, language, or general adaptive cognitive score < 70 (less than 2 standard deviations below the mean), need for hearing aids or cochlear implants, bilateral visual impairment (one or more of the following: no response to a 1 cm object, small eye, corneal scarring, sustained sensory nystagmus, ophthalmologist report of retinopathy of prematurity stage 3 or greater, or a report of visual acuity of 20/70 or worse), or cerebral palsy with a Gross Motor Function Classification System [23] level 3 or higher.
Ten easy to understand clinical scenarios were created to align with the CNFUN definition of severe neurodevelopmental impairment (Appendix A). Six scenarios captured children with a single “severe” impairment (cerebral palsy, Bayley-III motor, language, or cognitive score < 70, hearing or visual impairment). Five scenarios represented the most common combinations of impairments observed in the CNFUN database of very preterm infants. Finally, an eleventh scenario, used as a control condition, described a typically developing child. The scenarios were developed, reviewed, and edited for face validity by an interdisciplinary team of neonatal follow-up healthcare providers at British Columbia’s Women’s Hospital Neonatal Follow-Up Program and for acceptability by parent representatives. For each scenario, respondents were asked whether the fictional child did or did not have a severe health condition and to rate the severity of the health states on a scale from 0 (worst possible health) to 10 (best possible health). Scenarios were translated from English to French and back-translated to English for validity. Parent reviewers recommended reducing the questionnaire burden by limiting each questionnaire to six scenarios. Twelve questionnaires with different combinations of six scenarios, all including the scenario of the control child, were created using the Research Electronic Data Capture platform. Participants were randomized to receive one of the twelve questionnaires.

2.2. Survey Administration

Eligible participants were recruited in two steps: a local pilot study followed by a wide distribution of the questionnaire. During the pilot step, parents of children born at less than 29 weeks’ gestation attending a clinic visit at 3 to 5 years of age at the British Columbia’s Women’s Hospital Neonatal Follow-Up Program in Vancouver, Canada, were invited to participate. During the second step, an online snowball-sampling method was used [24] and respondent eligibility expanded to Canadian and international stakeholders. Demographic questions were added to describe the various stakeholder groups. The initial link to the online survey originated within the private Facebook groups of the parent stakeholder partners Canadian Premature Babies Foundation, Préma-Québec, and the Child Health Initiatives Limiting Disability—Brain Research Improving Growth and Health Trajectories network. Respondents were encouraged to share the link with others and the invitation was distributed to online parent-support sites. The survey was available in English or French from April 2021 to June 2021.

2.3. Statistical Analysis

Respondents were described and compared for each of the sampling populations (pilot phase, national, and international snowball samples) to evaluate whether the population survey results could be combined.
The scenarios were ranked according to median and mean health-scores. In our primary analysis we treated the health scores as continuous data and estimated adjusted mean differences between the control and severe neurodevelopmental impairment scenarios with 95% confidence intervals using a linear mixed-effects model. We adjusted for potential differential responses between the pilot phase and the snowball sample and Canadian and international respondents, and by respondent characteristic (parent versus other) by including interaction terms. As a sensitivity analysis, the responses were treated ordinally, and a mixed-effects proportional-odds model was fitted. In all models, random intercepts were included.
The proportion of scenario responses that were perceived as a severe health condition were calculated for each scenario. A mixed-effects logistic regression model, adjusting for the same confounders as above was used, with a binary response for each scenario of “severe” vs. “not severe”. Results were summarized as adjusted odd ratios and 95% confidence intervals.

2.4. Ethics

Participants were informed about the goal of the study and informed consent was sought at the beginning of the survey. The survey was anonymous and only accessible if consent was given. Research ethics board approval was obtained from the University of British Columbia Children’s and Women’s Research Ethics Board (H17-03490).

3. Results

3.1. Population Characteristics

Overall, 827 participants responded to a total of 4553 clinical scenarios. During the pilot phase, 62 parents attending a neonatal follow-up clinic in Vancouver completed the questionnaire. In the snowball step, 765 stakeholders answered the questionnaire (442 Canadian and 323 international). Participant demographics were obtained from respondents in the snowball step. Respondent age varied from less than 20 years to a maximum of more than 65 years with 47% of the participants aged 31 to 40 years old. Surveys were completed in English by 43% and in French by 57% of respondents. Most (60%) participants were parents, children, or family members and 28% were healthcare professionals (Table 1).
The regression analyses, using mixed-effects models to evaluate the effect of the recruitment sample, showed that the responses of parents in the pilot study and stakeholders in the second stage of the study were similar with no statistical association with scenario rating. (Figure 1) Results were therefore combined for subsequent analyses. The language of the questionnaire, English versus French, was also not associated with responses.

3.2. Severity Rating

The median, mean, and distribution of severity ratings of the clinical scenarios are shown in Figure 2. As expected, the typically developing child was perceived to represent the best possible health state with a median score of 10. The other scenarios had median scores between 6 and 8 with considerable spread.
Figure 3 shows that the mean differences and 95% confidence intervals between the control and other scenarios were all statistically significantly different. The scenario which describes a child with cerebral palsy and language delay was perceived to be the lowest-rated health condition with a mean difference from the control of −4.28 (95% confidence interval −4.43, −4.13) whereas the scenario describing a child with significant cognitive delay showed the smallest mean difference of −2.04 (95% confidence interval −2.21, −1.88). Results were similar when the responses were treated ordinally.

3.3. Classification of Scenario as a Severe Health Condition

Figure 4 displays the percentage of respondents who perceived the impairment of the child described in the scenario as being severe. For 8 of the 10 scenarios representing a “severe neurodevelopmental impairment”, fewer than 50% of the respondents perceived the health condition as severe. The scenario representing a child with cerebral palsy and language delay was considered severe by the largest percentage (55.5%) and a visual impairment rated severe by 51% of respondents. The scenario representing a child with cognitive delay was classified as severe by the smallest proportion (4.7%) of respondents.

3.4. Comparison of Respondent Characteristics

There were no statistically significant differences in severity rating between respondents recruited during the pilot phase in the neonatal follow-up clinic and in the national and international surveys. Non-parent (healthcare professionals, children born preterm, teachers, researchers, trainees) answers were similar to parents, except for the cerebral palsy and language delay scenario, where non-parents rated the scenario slightly lower than parents with a mean difference of −0.36 (95% confidence interval −0.66, −0.05) (Table 2). Respondent gender, age, and language of survey completion were not associated with survey responses.

4. Discussion

In this study we captured stakeholders’ perspectives regarding the rating and definition of severe neurodevelopmental impairment following very preterm birth. The 10 different health conditions that represent traditional severe neurodevelopmental impairments had median health scores ranging from 6 to 8 on a scale from 0 to 10. As expected, the health scores were all significantly lower than the typically developing child scenario. Importantly, most respondents did not perceive the scenarios to represent severe health conditions. Yet, all scenarios illustrated a case in which the child would have been labelled as having a “severe” or “significant” impairment according to definitions used in many neonatal outcome studies.
Our first finding is that stakeholders, parents, and clinicians generally rated the clinical scenarios more favorably than expected. This is important because the term “severe neurodevelopmental impairment” is used to make professional recommendations about life and death decisions. These outcomes are also used to communicate with parents and prepare them for the future. Our results identify the potential for miscommunication when the term “severe” is used. Indeed, severe can have a different meaning for different people. For some, it may indicate that a condition is more serious and therefore requires more attention. For others, the word may evoke more negative qualifiers such as undesirable or bad, which may promote stigma that can particularly affect individuals with developmental disabilities and their family [25]. This could be potentially avoided by describing outcomes using neutral descriptions such as grading and staging, as used for certain medical conditions. For example, the term “severe hearing impairment” can be replaced with “the need for hearing aids or a cochlear implant to function” which describes the practical impact of the condition without a judgement on the desirability of the condition. There is a need to review the terminology used to describe outcomes after preterm birth by including stakeholders’ perspectives.
Our second finding is that not all impairments classified as severe by clinicians and researchers are comparable: is being blind worse than being deaf? In our study a visual impairment was considered worse than hearing loss. Yet, these individual conditions are often combined into a composite endpoint in neonatal outcome studies and trials. Composite outcomes are useful to increase trial statistical efficiency, but rules exist to ensure their validity and interpretability [18,19,20]. One key element is that individual components should carry similar importance to stakeholders. Our results show that the definition of severe neurodevelopmental impairment used in this study does not meet the criteria of similar importance. Furthermore, for many scenarios, there was a wide variability in the responses indicating the subjective nature of the term “severe”. Cerebral palsy may be considered worse by parents who are professional athletes, compared to parents who live with a motor disability, and hearing loss may be considered more impactful by parents who are musicians. Our findings question whether using the current CNFUN definition of severe neurodevelopmental impairment is valid. The same conclusion is likely to be generalizable to other similar composite outcomes.
Our third finding is that, overall, clinicians and parents/families who participated in this study had similar responses. This is in contrast with studies showing that quality of life is valued differently by healthcare providers, parents, and adolescents born very preterm: clinicians generally being more pessimistic than parents and preterm survivors [26]. Webbe et al. also reported that the importance of neonatal outcomes was considered differently by clinicians and parents [27]. Other studies using clinical vignettes in neonatology have demonstrated a similar phenomenon: when study participants are exposed to a story with descriptive outcomes or functional outcomes (as opposed to terms like “a 24-weeker” or “severe disability”) clinicians tend to value patients more and/or non-clinicians and clinicians tend to answer similarly [28]. However, severe is a subjective term and we identified variability amongst our respondents.
Our results should be interpreted with consideration of the clinical scenarios used in the study. The scenarios described the developmental status of young children and not their future trajectories. This was necessary, especially for the clinical scenarios representing Bayley-III scores since there are limitations to their predictive ability [29]. For example, about half the children with “severe neurodevelopmental impairment” were not categorized as “severe” when evaluated at 5 years of age in the Caffeine for Apnea in Prematurity trial [8]. Severe neurodevelopmental impairment encompasses a spectrum of health conditions. The scenarios used in this study described less severe conditions on this spectrum.
Our mixed-methods research program aimed to capture the voices of parents about their children who were born preterm and address biases and barriers to participation by using qualitative [30] and quantitative [31,32] methods, including parents with participation barriers [33] and, in this study, a broader range of stakeholders using scenarios. In these studies, parents reported that positive, as well as negative, aspects of very preterm children’s health and development [30,31] should be reported and that there are other outcomes such as nutrition, rehospitalizations, behavior, and sleep that are important to them [31,32].
In neonatal follow-up research [4,8,15,16,17,34] most outcomes have been selected by individual groups of neonatologists, researchers, or clinicians without consideration for what parents or families consider important or impactful. Parents need appropriate information described in understandable terms to make the best decision for their children. Considering our results, more consideration is warranted by researchers and clinicians in the choice and definition of outcome measures and how information is shared with families. We recommend avoidance of the term “severe” and propose that objective practical descriptors, such as “need for hearing aids or cochlear implant to function” should be used. The terminology to describe the functional impact of outcomes needs to be developed together with parent and stakeholder partners. Our study provided a voice for parents of children born preterm and other key stakeholders to guide how outcomes should be reported during follow-up and research programs.
This study had some limitations. Several factors may have affected responses to these hypothetical scenarios. Respondent characteristics and lived experiences vary and may change over time. Parents who are active on online support groups are possibly different from parents who are not; the same can be said about clinicians. This community of stakeholders is likely to influence new parents of preterm infants who turn to online support groups. These are also self-reported questionnaires with their inherent biases, limiting the participation of parents with limited literacy or who speak different languages. On the other hand, parent respondents in the local pilot group, who were not affected by these sampling biases, had similar answers. The large number of respondents from different backgrounds ensured that many diverse stakeholder voices were heard.

5. Conclusions

This study shows that the assessment of severity based on a clinical scenario differs from commonly used definitions of severe neurodevelopmental impairment used in outcomes research. Secondly, it highlights the problems of using a composite outcome to describe neurodevelopmental impairment. Optimizing the way neonatal outcomes are reported is essential. Further research is needed to identify which outcomes are most meaningful to parents and how to effectively communicate outcomes to families.

Author Contributions

Conceptualization, A.S., R.P., C.J.B. and T.M.L.; methodology, A.S., C.J.B., A.J., S.Z.-J. and T.M.L.; formal analysis, J.N.B.; investigation, A.S., A.C., L.L.R., A.J. and T.M.L.; resources, A.S. and J.N.B.; data curation, A.C., L.L.R. and J.N.B.; writing—original draft preparation, A.S. and A.C.; writing—review and editing, A.S., A.C., L.L.R., J.N.B., S.Z.-J., R.P., C.J.B., A.J. and T.M.L.; visualization, A.S., A.C. and J.N.B.; supervision, A.S., L.L.R. and T.M.L.; project administration, A.S., L.L.R. and T.M.L.; funding acquisition, A.S. C.J.B., A.J. and T.M.L. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the Child Health Initiatives Limiting Disability—Brain Research Improving Growth and Health Trajectories (CHILD—BRIGHT) Network, with funding from the Canadian Institutes of Health Research (CIHR) under the Strategy for Patient-Oriented Research grant number SCA-145104 with matching funding from Michael Smith Foundation for Health Research. A.J. and T.M.L. received salary support from the Fonds de Recherche en Santé du Québec. A.C. and S.Z.-J. received summer student salaries from CHILD—BRIGHT. CIHR and the funding support had no role in the design and conduct of the study.

Institutional Review Board Statement

The study was conducted in accordance with the Declaration of Helsinki, and approved by the Research Ethics Board from the University of British Columbia Children’s and Women’s Research Ethics Board (Protocol H17-03490 date of approval: 9 March 2018).

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study.

Data Availability Statement

The data presented in this study are available on request from the corresponding author.

Acknowledgments

The authors thank all the respondents who completed the survey. We would also like to thank all the clinicians and parents and the coordinators of the Canadian Premature Babies Foundation and Canadian Institutes of Health Research (CIHR) under the Strategy for Patient-Oriented Research grant number SCA-145104 who contributed to the study.

Conflicts of Interest

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.

Abbreviations

Bayley-III—Bayley Scales of Infant and Toddler Development third edition; CNFUN—Canadian Neonatal Follow-Up Network.

Appendix A. Clinical Scenarios

SCENARIO 1 (Cerebral palsy)
Jamie is an 18-month-old child. He can sit with support and roll and creep on his stomach. He has stiff legs and will very likely use a wheelchair for longer distances at school. He can see and hear normally. He learns like other children his age and likes to play with other children. He can follow simple directions and use words like other children his age.
SCENARIO 2 (Motor impairment)
Riley is an 18-month-old child. She was slower at learning how to roll and sit. She now walks like an 11- to 12-month-old instead of an 18-month-old child. She will take three steps by herself but is unsteady and falls often. She can hold a crayon but is not able to scribble. She can see and hear normally. She is learning to play with toys like other children her age and likes to play with other children. She can follow simple directions and use words like other children her age.
SCENARIO 3 (Cognitive impairment)
Max is an 18-month-old child. He likes to play with toys for younger children (10–12 months). He takes more time to learn new skills and needs more help doing so, compared to other children his age. He can see and hear normally. He walks, runs, and moves like other children his age. He can follow simple directions and use words like other children his age.
SCENARIO 4 (Language impairment)
Lina is an 18-month-old child. She says ‘mama’ and ‘dada’ and one other word, which is less than expected for her age. She does not point to her ears and eyes when asked. She does not use words to make her wants known but cries or grabs you instead. She can see and hear normally. She walks, runs, and moves like other children her age. She learns, plays, and explores the environment like other children her age.
SCENARIO 5 (Visual impairment)
Alex is an 18-month-old child. He is blind in both eyes but can see light and shadows with poor clarity. He can hear normally. He can walk at home but needs help to find his way and be safe outside, since he cannot see well. He is curious and plays and learns like other children his age except where good vision is needed. He can follow simple verbal directions and use words like other children his age.
SCENARIO 6 (Hearing impairment)
Emilia is an 18-month-old child. With a hearing aid, she hears well but has difficulty in noisy environments. Without the hearing aid, she cannot understand regular speech. She can see normally. She learns, plays, and explores the environment like other children her age, but with the use of a hearing aid. With a hearing aid and regular speech therapy, she can follow simple directions and use words like other children her age. She walks, runs, and moves like other children her age.
SCENARIO 7 (Motor and language impairment)
Ali is an 18-month-old child. He was slower at learning how to roll and sit. He now walks like an 11- to 12-month-old instead of an 18-month-old child. He will take three steps by himself but is unsteady and falls often. He can hold a crayon but is not able to scribble. He says ‘mama’ and ‘dada’ and one other word, which is less than expected for his age. He does not point to his ears and eyes when asked. He does not use words to make his wants known but cries or grabs you instead. He can see and hear normally. He is learning to play with toys like other children his age and likes to play with other children.
SCENARIO 8 (Cognitive and language impairment)
Gracie is an 18-month-old child. She likes to play with toys for younger children (10–12 months). She takes more time to learn new skills and needs more help doing so, compared to other children her age. She says ‘mama’ and ‘dada’ and one other word, which is less than expected for her age. She does not point to her ears and eyes when asked. She does not use words to make her wants known but cries or grabs you instead. She can see and hear normally. She walks, runs, and moves like other children her age.
SCENARIO 9 (Motor and cognitive impairment)
Lee is an 18-month-old child. He was slower at learning how to roll and sit. He now walks like an 11- to 12-month-old instead of an 18-month-old child. He will take three steps by himself but is unsteady and falls often. He can hold a crayon but is not able to scribble. He likes to play with toys for younger children (10–12 months). He takes more time to learn new skills and needs more help doing so, compared to other children his age. He can see and hear normally. He can follow simple directions and use words like other children his age.
SCENARIO 10 (Cerebral palsy and language impairment)
Bailey is an 18-month-old child. She can sit with support and roll and creep on her stomach. She has stiff legs and will very likely use a wheelchair for longer distances at school. She says ‘mama’ and ‘dada’ and one other word, which is less than expected for her age. She does not point to her ears and eyes when asked. She does not use words to make her wants known but cries or grabs you instead. She can see and hear normally. She learns like other children her age and likes to play with other children.
SCENARIO 11 (Typically developing child)
Tasha is an 18-month-old child. She can see and hear normally. She walks, runs, and moves like other children her age. She learns, plays, and explores the environment like other children her age. She can follow simple directions and use words like other children her age.
Questions:
If 0 is the worst possible health and 10 is the best possible health, where do you think __ fits on the scale?
_0 _1 _2 _3 _4 _5 _6 _7 _8 _9 _10
Does __’s case describe a severe health condition?
_Y _N
(repeat for all scenarios)

References

  1. Walani, S.R. Global burden of preterm birth. Int. J. Gynecol. Obstet. 2020, 150, 31–33. [Google Scholar] [CrossRef] [PubMed]
  2. Centers for Disease Control. Preterm Birth. Available online: https://www.cdc.gov/reproductivehealth/maternalinfanthealth/pretermbirth.htm#print (accessed on 1 April 2023).
  3. Shah, P.S.; Ye, X.Y.; Yang, J.; Campitelli, M.A. Preterm birth and stillbirth rates during the COVID-19 pandemic: A population-based cohort study. CMAJ. 2021, 193, E1164–E1172. [Google Scholar] [CrossRef] [PubMed]
  4. Bell, E.F.; Hintz, S.R.; Hansen, N.I.; Bann, C.M.; Wyckoff, M.H.; DeMauro, S.B.; Walsh, M.C.; Vohr, B.R.; Stoll, B.J.; Carlo, W.A.; et al. Mortality, In-Hospital Morbidity, Care Practices, and 2-Year Outcomes for Extremely Preterm Infants in the US, 2013–2018. JAMA 2022, 327, 248–263. [Google Scholar] [CrossRef] [PubMed]
  5. Stephens, A.; Lain, S.; Roberts, C.; Bowen, J.R.; Nassar, N. Survival, Hospitalization, and Acute-Care Costs of Very and Moderate Preterm Infants in the First 6 Years of Life: A Population-Based Study. J. Pediatr. 2016, 169, 61–68.e3. [Google Scholar] [CrossRef] [PubMed]
  6. Petrou, S.; Eddama, O.; Mangham, L. A structured review of the recent literature on the economic consequences of preterm birth. Arch. Dis. Child.-Fetal Neonatal Ed. 2010, 96, F225–F232. [Google Scholar] [CrossRef]
  7. Drillien, C.M. Growth and Development in a Group of Children of Very Low Birth Weight. Arch. Dis. Child. 1958, 33, 10–18. [Google Scholar] [CrossRef] [PubMed]
  8. Schmidt, B.; Anderson, P.J.; Doyle, L.W.; Dewey, D.; Grunau, R.E.; Asztalos, E.V.; Davis, P.G.; Tin, W.; Moddemann, D.; Solimano, A.; et al. Survival without disability to age 5 years after neonatal caffeine therapy for apnea of prematurity. JAMA 2012, 307, 275–282. [Google Scholar] [CrossRef]
  9. Bayley, N. Manual for the Bayley Scales of Infant and Toddler Development, 3rd ed.; The Psychological Corporation: San Antonio, TX, USA, 2006. [Google Scholar]
  10. Albaghli, F.; Church, P.; Ballantyne, M.; Girardi, A.; Synnes, A. Neonatal follow-up programs in Canada: A national survey. Paediatr. Child Heal. 2021, 26, e46–e51. [Google Scholar] [CrossRef]
  11. Follow-up Care of High-Risk Infants. Pediatrics 2004, 114 (Suppl. S5), 1377–1397. [CrossRef]
  12. Ramachandran, S.; Foglia, E.E.; DeMauro, S.B.; Chawla, S.; Brion, L.P.; Wyckoff, M.H. Perinatal management: Lessons learned from the neonatal research network. Semin. Perinatol. 2022, 46, 151636. [Google Scholar] [CrossRef]
  13. Mactier, H.; Bates, S.E.; Johnston, T.; Lee-Davey, C.; Marlow, N.; Mulley, K.; Smith, L.K.; To, M.; Wilkinson, D. Perinatal management of extreme preterm birth before 27 weeks of gestation: A framework for practice. Arch. Dis. Child. Fetal Neonatal Ed. 2020, 105, 232–239. [Google Scholar] [CrossRef] [PubMed]
  14. Haward, M.F.; Payot, A.; Feudtner, C.; Janvier, A. Personalized communication with parents of children born at less than 25 weeks: Moving from doctor-driven to parent-personalized discussions. Semin. Perinatol. 2020, 46, 151551. [Google Scholar] [CrossRef] [PubMed]
  15. Synnes, A.; Luu, T.M.; Moddemann, D.; Church, P.; Lee, D.; Vincer, M.; Ballantyne, M.; Majnemer, A.; Creighton, D.; Yang, J.; et al. Determinants of developmental outcomes in a very preterm Canadian cohort. Arch. Dis. Child.-Fetal Neonatal Ed. 2017, 102, F235–F234. [Google Scholar] [CrossRef] [PubMed]
  16. Haslam, M.D.; Lisonkova, S.; Creighton, D.; Church, P.; Yang, J.; Shah, P.S.; Joseph, K.; Synnes, A.; Harrison, A.; Ting, J.; et al. Severe Neurodevelopmental Impairment in Neonates Born Preterm: Impact of Varying Definitions in a Canadian Cohort. J. Pediatr. 2018, 197, 75–81.e4. [Google Scholar] [CrossRef]
  17. Rysavy, M.A.; Horbar, J.D.; Bell, E.F.; Li, L.; Greenberg, L.T.; Tyson, J.E.; Patel, R.M.; Carlo, W.A.; Younge, N.E.; Green, C.E.; et al. Assessment of the Neonatal Research Network Extremely Preterm Birth Outcome Model in the Vermont Oxford Network. JAMA Pediatr. 2020, 174, e196294. [Google Scholar] [CrossRef] [PubMed]
  18. Montori, V.M.; Permanyer-Miralda, G.; Ferreira-González, I.; Busse, J.; Pacheco-Huergo, V.; Bryant, D.; Alonso, J.; A Akl, E.; Domingo-Salvany, A.; Mills, E.; et al. Validity of composite end points in clinical trials. BMJ 2005, 330, 594–596. [Google Scholar] [CrossRef]
  19. Ferreira-González, I.; Permanyer-Miralda, G.; Busse, J.; Bryant, D.; Montori, V.; Alonso-Coello, P.; Walter, S.D.; Guyatt, G.H. Methodologic discussions for using and interpreting composite endpoints are limited, but still identify major concerns. J. Clin. Epidemiology 2007, 60, 651–657, discussion 658–662. [Google Scholar] [CrossRef]
  20. Cordoba, G.; Schwartz, L.; Woloshin, S.; Bae, H.; Gøtzsche, P.C. Definition, reporting, and interpretation of composite outcomes in clinical trials: Systematic review. BMJ 2010, 341, c3920. [Google Scholar] [CrossRef]
  21. CHILD-BRIGHT Network. What Is CHILD-BRIGHT. Available online: https://www.child-bright.ca (accessed on 25 October 2022).
  22. Canadian Neonatal Follow-Up Network. Outcomes Definitions in Canadian Neonatal Follow-Up Network Annual Report 2021. 17. Available online: https://canadianneonatalfollowup.ca/annual-report/ (accessed on 1 April 2023).
  23. Palisano, R.; Rosenbaum, P.; Walter, S.; Russell, D.; Wood, E.; Galuppi, B. Development and reliability of a system to classify gross motor function in children with cerebral palsy. Dev. Med. Child Neurol. 1997, 39, 214–223. [Google Scholar] [CrossRef]
  24. Glen, S. Snowball Sampling: Definition, Advantages and Disadvantages. Available online: https://www.statisticshowto.com/probability-and-statistics/statistics-definitions/snowball-sampling/ (accessed on 25 October 2022).
  25. Werner, S.; Shulman, C. Subjective well-being among family caregivers of individuals with developmental disabilities: The role of affiliate stigma and psychosocial moderating variables. Res. Dev. Disabil. 2013, 34, 4103–4114. [Google Scholar] [CrossRef]
  26. Saigal, S. Quality of life of former premature infants during adolescence and beyond. Early Hum. Dev. 2013, 89, 209–213. [Google Scholar] [CrossRef] [PubMed]
  27. Webbe, J.W.H.; Duffy, J.M.N.; Afonso, E.; Al-Muzaffar, I.; Brunton, G.; Greenough, A.; Hall, N.J.; Knight, M.; Latour, J.M.; Lee-Davey, C.; et al. Core outcomes in neonatology: Development of a core outcome set for neonatal research. Arch. Dis. Child.-Fetal Neonatal Ed. 2020, 105, 425–431. [Google Scholar] [CrossRef]
  28. Janvier, A.; Lantos, J.; Deschênes, M.; Couture, E.; Nadeau, S.; Barrington, K.J. Caregivers attitudes for very premature infants: What if they knew? Acta Paediatr. 2008, 97, 276–279. [Google Scholar] [CrossRef] [PubMed]
  29. Anderson, P.J.; Burnett, A. Assessing developmental delay in early childhood — Concerns with the Bayley-III scales. Clin. Neuropsychol. 2017, 31, 371–381. [Google Scholar] [CrossRef] [PubMed]
  30. Jaworski, M.; Janvier, A.; Lefebvre, F.; Luu, T.M. Parental Perspectives Regarding Outcomes of Very Preterm Infants: Toward a Balanced Approach. J. Pediatr. 2018, 200, 58–63.e1. [Google Scholar] [CrossRef]
  31. Jaworski, M.; Janvier, A.; Bourque, C.J.; Mai-Vo, T.-A.; Pearce, R.; Synnes, A.R.; Luu, T.M. Parental perspective on important health outcomes of extremely preterm infants. Arch. Dis. Child.-Fetal. Neonatal. Ed. 2021, 107, 495–500. [Google Scholar] [CrossRef]
  32. Milette, A.A.; Richter, L.L.; Bourque, C.J.; Janvier, A.; Pearce, R.; Church, P.T.; Synnes, A.; Luu, T.M. Parental perspectives of outcomes following very preterm birth: Seeing the good, not just the bad. Acta Paediatr. 2023, 112, 398–408. [Google Scholar] [CrossRef] [PubMed]
  33. Richter, L.L.; Luu, T.M.; Janvier, A.; Pearce, R.; Bourque, C.J.; Church, P.; Synnes, A. Investigating the agreement between parents’ classification of their very preterm child’s neurodevelopmental impairment status and the Canadian Neonatal Follow up Network classification. In Proceedings of the Canadian National Perinatal Research Meeting, Montebello, CA, Canada, 11 February 2021. [Google Scholar]
  34. Allen, M.C. Preterm outcomes research: A critical component of neonatal intensive care. Ment. Retard. Dev. Disabil. Res. Rev. 2002, 8, 221–233. [Google Scholar] [CrossRef]
Figure 1. Mean difference between scenario and control by population samples. CI, confidence interval; CP, cerebral palsy; MOT, motor impairment; COG, cognitive impairment; LANG, language delay; VI, visual impairment; HI, hearing impairment.
Figure 1. Mean difference between scenario and control by population samples. CI, confidence interval; CP, cerebral palsy; MOT, motor impairment; COG, cognitive impairment; LANG, language delay; VI, visual impairment; HI, hearing impairment.
Children 10 00880 g001
Figure 2. Boxplot of distribution of ratings of clinical scenarios. Median values are shown in the whisker plots and means appear numerically underneath. NO, no impairment; CP, cerebral palsy; MOT, motor impairment; COG, cognitive impairment; LANG, language delay; VI, visual impairment; HI, hearing impairment.
Figure 2. Boxplot of distribution of ratings of clinical scenarios. Median values are shown in the whisker plots and means appear numerically underneath. NO, no impairment; CP, cerebral palsy; MOT, motor impairment; COG, cognitive impairment; LANG, language delay; VI, visual impairment; HI, hearing impairment.
Children 10 00880 g002
Figure 3. Mean differences in ratings between scenarios representing a severe neurodevelopmental impairment condition and the scenario describing a typically developing child. Results show mean differences and 95% confidence intervals (CIs). NO, no impairment; CP, cerebral palsy; MOT, motor impairment; COG, cognitive impairment; LANG, language delay; VI, visual impairment; HI, hearing impairment.
Figure 3. Mean differences in ratings between scenarios representing a severe neurodevelopmental impairment condition and the scenario describing a typically developing child. Results show mean differences and 95% confidence intervals (CIs). NO, no impairment; CP, cerebral palsy; MOT, motor impairment; COG, cognitive impairment; LANG, language delay; VI, visual impairment; HI, hearing impairment.
Children 10 00880 g003
Figure 4. Proportion of clinical scenarios perceived to be a severe health condition. Results exclude missing and ‘don’t know’ responses.
Figure 4. Proportion of clinical scenarios perceived to be a severe health condition. Results exclude missing and ‘don’t know’ responses.
Children 10 00880 g004
Table 1. Characteristics of participants who completed the survey by the snowball method.
Table 1. Characteristics of participants who completed the survey by the snowball method.
CharacteristicN (%) (N = 827)
Language of QuestionnaireEnglish354 (43%)
French473 (57%)
Personal
or Professional Description
Parent/caregiver or family of a child born preterm471 (57%)
Person born preterm21 (3%)
Healthcare professional228 (28%)
Teacher/educator14 (2%)
Student/trainee5 (1%)
Researcher14 (2%)
Other9 (1%)
Country of Residence (international survey only)United States54 (6.5%)
United Kingdom26 (3.1%)
France181 (21.9%)
Other62 (7.5%)
N = number.
Table 2. Comparison of parent and non-parent respondents for severity ranking of different scenarios.
Table 2. Comparison of parent and non-parent respondents for severity ranking of different scenarios.
ScenarioMean Differences (95% CI)p Value
No impairment−0.06 (−0.3, 0.17)0.60
Cerebral palsy−0.23 (−0.61, 0.16)0.25
Motor−0.04 (−0.32, 0.25)0.81
Cognitive0.25 (−0.09, 0.59)0.16
Language0.14 (−0.2, 0.48)0.41
Visual impairment0.03 (−0.36, 0.41)0.89
Hearing impairment−0.22 (−0.46, 0.2)0.07
Motor and language0 (−0.34, 0.33)0.99
Language and cognitive0.24 (−0.08, 0.55)0.14
Motor and cognitive−0.03 (−0.34, 0.28)0.83
Cerebral palsy and language−0.36 (−0.66, −0.05) 0.02
CI, confidence interval.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Synnes, A.; Chera, A.; Richter, L.L.; Bone, J.N.; Bourque, C.J.; Zhang-Jiang, S.; Pearce, R.; Janvier, A.; Luu, T.M. Redefining Neurodevelopmental Impairment: Perspectives of Very Preterm Birth Stakeholders. Children 2023, 10, 880. https://doi.org/10.3390/children10050880

AMA Style

Synnes A, Chera A, Richter LL, Bone JN, Bourque CJ, Zhang-Jiang S, Pearce R, Janvier A, Luu TM. Redefining Neurodevelopmental Impairment: Perspectives of Very Preterm Birth Stakeholders. Children. 2023; 10(5):880. https://doi.org/10.3390/children10050880

Chicago/Turabian Style

Synnes, Anne, Amarpreet Chera, Lindsay L. Richter, Jeffrey N. Bone, Claude Julie Bourque, Sofia Zhang-Jiang, Rebecca Pearce, Annie Janvier, and Thuy Mai Luu. 2023. "Redefining Neurodevelopmental Impairment: Perspectives of Very Preterm Birth Stakeholders" Children 10, no. 5: 880. https://doi.org/10.3390/children10050880

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop